Cumberland Pharmaceuticals Inc. Sales Allowances, Goods (Deprecated 2018-01-31)
Cumberland Pharmaceuticals Inc. (CPIX) reported Sales Allowances, Goods (Deprecated 2018-01-31) of $400.00 thousand for the 3-month period ending 2011-12-31, per its 10-K filed 2014-03-11.
Discontinued › Notes
us-gaap:SalesAllowancesGoods · last filed 2014-03-11
- Cumberland Pharmaceuticals Inc. sales allowances, goods (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $400.00K.
| Period end | Sales Allowances, Goods (Deprecated 2018-01-31) 3 month |
|---|---|
| 2011-12-31 | $400.00K 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |